Vhanmane Priyanka, Nandy Rishi, Mangalekar Sachin B, Rai Jeeth, Sagare Shweta V, Kumbhare Shruti
Department of Periodontology, Bharati Vidyapeeth (Deemed to be University), Pune, Dental College and Hospital, Sangli, Maharashtra, India.
Department of Conservative and Endodontics, Bharati Vidyapeeth (Deemed to be University), Pune, Dental College and Hospital, Sangli, Maharashtra, India.
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2250-S2252. doi: 10.4103/jpbs.jpbs_193_24. Epub 2024 May 22.
Chronic periodontitis is a prevalent inflammatory condition affecting the supporting structures of teeth. Adjunctive therapies to scaling and root planing (SRP) play a crucial role in enhancing treatment outcomes. This study aimed to compare the clinical effectiveness of subgingivally delivered 0.5% azithromycin gel and 1% chlorhexidine gel as adjuncts to SRP in the management of chronic periodontitis.
A comparative clinical evaluation was conducted involving 60 participants diagnosed with chronic periodontitis. They were randomly assigned to two groups: Group A received subgingival application of 0.5% azithromycin gel after SRP, whereas Group B received 1% chlorhexidine gel in a similar manner. Clinical parameters including probing pocket depth (PPD), clinical attachment level (CAL), and gingival index (GI) were recorded at baseline and 3-month follow-up.
Both groups demonstrated significant improvements in clinical parameters after treatment. However, Group A exhibited a greater reduction in PPD (mean decrease of 2.5 mm) compared with Group B (mean decrease of 1.8 mm). Similarly, Group A showed a higher gain in CAL (mean gain of 2.3 mm) compared with Group B (mean gain of 1.5 mm). In addition, a significant reduction in GI was observed in both groups, with Group A showing slightly better outcomes.
Subgingivally delivered 0.5% azithromycin gel demonstrated superior clinical efficacy as an adjunct to SRP in the treatment of chronic periodontitis compared with 1% chlorhexidine gel. The findings suggest that azithromycin gel may serve as a promising therapeutic option in managing periodontal disease.
慢性牙周炎是一种常见的炎症性疾病,会影响牙齿的支持结构。龈下刮治术和根面平整术(SRP)的辅助治疗在提高治疗效果方面起着关键作用。本研究旨在比较龈下应用0.5%阿奇霉素凝胶和1%氯己定凝胶作为SRP辅助治疗慢性牙周炎的临床效果。
对60名被诊断为慢性牙周炎的参与者进行了一项比较临床评估。他们被随机分为两组:A组在SRP后接受龈下应用0.5%阿奇霉素凝胶,而B组以类似方式接受1%氯己定凝胶。在基线和3个月随访时记录包括探诊深度(PPD)、临床附着水平(CAL)和牙龈指数(GI)在内的临床参数。
两组在治疗后临床参数均有显著改善。然而,与B组(平均减少1.8mm)相比,A组的PPD减少幅度更大(平均减少2.5mm)。同样,与B组(平均增加1.5mm)相比,A组的CAL增加更高(平均增加2.3mm)。此外,两组的GI均显著降低,A组的结果略好。
与1%氯己定凝胶相比,龈下应用0.5%阿奇霉素凝胶作为SRP辅助治疗慢性牙周炎具有更好的临床疗效。研究结果表明,阿奇霉素凝胶可能是治疗牙周疾病的一种有前景的治疗选择。